Plasmapheresis for Medical Disorders: Dr. Amber Paratore Sanchez Speaking at This Week’s Grand Rounds

Dr. Amber SanchezDr. Amber Sanchez will speak on plasmapheresis for medical disorders at the October 22 session of Medicine Grand Rounds.

A former UC San Diego chief medical resident (2006-2007) who is now on the internal medicine faculty, Amber Paratore Sanchez, MD, is Health Sciences assistant clinical professor in the Division of Nephrology-Hypertension.

She is associate medical director of the Therapeutic Apheresis Program at UC San Diego Health System.

See her clinical profile

Dr. Lindia Willies-Jacobo on Promoting Health Equity: The Role of Diversity and Cultural Competency at Medicine Grand Rounds October 15

Lindia Willies-Jacobo, MDDr. Lindia Willies-Jacobo will present on promoting health equity at this week’s session of Medicine Grand Rounds.

Lindia Willies-Jacobo, MD, FAAP, is clinical professor of pediatrics and assistant dean for Diversity and Community Partnerships at the UC San Diego School of Medicine. She directs the Program in Medical Education – Health Equity (PRIME-HEq).

See Dr. Willies-Jacobo’s clinical profile

Big Data Sharing for Better Health

Researchers at University of California, San Diego School of Medicine have been awarded a $9.2 million grant to help modernize and transform how researchers share, use, find and cite biomedical datasets.

The 3-year project, in collaboration with The University of Texas Health Science Center at Houston, is part of a federal initiative to increase the utility of biomedical research data, launched this week by the National Institutes of Health (NIH) through its Big Data to Knowledge (BD2K) program. … Read the full story from the UC San Diego Newsroom


Dr. Lucila Ohno-MachadoLucila Ohno-Machado, MD, PhD, is lead investigator on the Biomedical and healthCAre Data Discovery and Indexing Ecosystem (BioCADDIE) project.

Dr. Ohno-Machado, professor of medicine, is founding chief of the Division of Biomedical Informatics.

Read the BioCADDIE project description on the NIH RePORTER

UC San Diego Part of New Effort to Fight Autoimmune Disorders

Major multi-year partnership will focus first on rheumatoid arthritis and lupus

The Division of Rheumatology, Allergy and Immunology at University of California, San Diego School of Medicine has been named a key site in a national, multi-institution, multi-year $41.6 million program to speed drug discovery, development, diagnostics and therapies for patients with autoimmune disorders, primarily rheumatoid arthritis (RA) and lupus erythematosus, which affect millions of Americans. …Read the full story from the UC San Diego Newsroom

Dr. Karl Hostetler on Discovery and Development of Brincidofovir (DNA Viruses) and 1968(HPV 16&18) October 1

Dr. Karl HostetlerDr. Karl Hostetler presents on the topic, “Discovery and Development of Brincidofovir (DNA Viruses) and 1968 (HPV 16&18)” at Medicine Grand Rounds on October 1.

Karl Hostetler, MD, is emeritus professor of medicine in the Division of Infectious Diseases at UC San Diego.

San Diego’s 2014 Top Doctors List Includes 44 from Department of Medicine

Forty-four physicians from the Department of Medicine are among over 100 UC San Diego Health System doctors named to the 2014 San Diego Top Doctors list. See the list for UC San Diego Health System.

Not present on that list are two additional internal medicine physicians who practice at the VA San Diego Healthcare System: Charles Goldberg, MD, and Simerjot Jassal, MD. Dr. Jassal directs the Internal Medicine Residency Program.

The Top Doctors list comes from the annual “Physicians of Exceptional Excellence” survey from the San Diego County Medical Society and San Diego Magazine.

Read the UC San Diego Health System press release

Dr. Alina Popa on “Teaching Tools for Medical Education” at Medicine Grand Rounds September 24

Alina Popa, MDAlina Popa, MD, speaks on the topic, “Teaching Tools for Medical Education” at Medicine Grand Rounds on September 24.

Dr. Popa is Health Sciences associate clinical professor in the Division of Hospital Medicine at UC San Diego.

Novel Drug Targeting Leukemia Cells Enters Clinical Trial

Researchers at the University of California, San Diego School of Medicine have launched a phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for patients with chronic lymphocytic leukemia (CLL), the most common form of blood cancer in adults. … Read the full story from the UC San Diego Newsroom


A team led by Dr. Thomas Kipps developed the new antibody, known as cirmtuzumab or UC-961. The work was conducted and supported by a California Institute for Regenerative Medicine HALT grant to co-principal investigators Dennis Carson, MD, and Catriona Jamieson, PhD, MD.

Dr. Thomas Kipps

Catriona H. M. Jamieson, MD, PhDDennis Carson, MD

L to R: Drs. Kipps, Jamieson and Carson.

Cancer and the Immune System: A Double-Edged Sword

Cell surface sugars can promote or inhibit cancer depending upon stage

During cancer development, tumor cells decorate their surfaces with sugar compounds called glycans that are different from those found on normal, healthy cells. In the Sept. 15 online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), researchers at the University of California, San Diego School of Medicine report that sialic acids at the tips of these cancer cell glycans are capable of engaging with immune system cells and changing the latter’s response to the tumor – for good and bad. … Read the full story from the UC San Diego Newsroom


Ajit Varki, MDPrincipal investigator of the study is Ajit Varki, MD, distinguished professor of medicine and cellular medicine, member of the UC San Diego Moores Cancer Center and co-director of both the Glycobiology Research and Training Center and UCSD/Salk Center for Academic Research and Training in Anthropogeny (CARTA).

Dr. Chip Schooley on “MERS, Ebola, Boeing and Bats” at Medicine Grand Rounds September 17

Dr. Robert T. "Chip" SchooleyDr. Robert T. “Chip” Schooley will speak on the topic “MERS, Ebola, Boeing and Bats” at Medicine Grand Rounds on September 17.  Dr. Schooley is professor of medicine, academic affairs vice chair of the Department of Medicine and chief of the Division of Infectious Diseases at UC San Diego.